uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Intramuscular transplantation of engineered hepatic tissue constructs corrects acute and chronic liver failure in mice
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Oncology, Radiology and Clinical Immunology, Clinical Immunology.
Show others and affiliations
2010 (English)In: Journal of Hepatology, ISSN 0168-8278, E-ISSN 1600-0641, Vol. 52, no 2, 211-219 p.Article in journal (Refereed) Published
Abstract [en]

Background & Aims: Transplantation of isolated hepatocytes holds great promise as ail alternative to whole organ liver transplantation. For treatment of liver failure, access to the portal circulation has significant risks and intrahepatic hepatocyte engraftment is poor. In advanced cirrhosis, transplantation into ail extrahepatic site is necessary and intrasplenic engraftment is short-lived. Strategies that allow repeated extrahepatic infusion of hepatocytes Could improve the efficacy and safety of hepatocyte transplantation for the treatment of liver failure. Methods: A non-immunogenic self-assembling peptide nanofiber (SAPNF) was developed as a three-dimensional scaffold and combined with growth factors derived from a conditionally immortalized human hepatocyte cell line to engineer a hepatic tissue graft that Would allow hepatocyte engraftment outside the liver. Results:The hepatic tissue Constructs maintained hepatocyte-specific gene expression and functionality in vitro. When transplanted into skeletal muscle as ail extrahepatic site for engraftment, the engineered hepatic grafts provided life-saving support in models of acute, fulminant, and chronic liver failure that recapitulates these clinical diseases. Conclusions: SAPNF-engineered hepatic Constructs engrafted and functioned as hepatic tissues within the muscle to provide life-sustaining liver Support. These engineered tissue Constructs contained no animal products that Would limit their development as a therapeutic approach.

Place, publisher, year, edition, pages
2010. Vol. 52, no 2, 211-219 p.
Keyword [en]
Hepatocytes, SAPNF, Extracellular matrix, Hepatocyte transplantation, Acute liver failure, Chronic liver failure, Hepatic tissue engineering
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-136908ISI: 000275390500012OAI: oai:DiVA.org:uu-136908DiVA: diva2:380251
Available from: 2010-12-21 Created: 2010-12-14 Last updated: 2010-12-21Bibliographically approved

Open Access in DiVA

No full text

By organisation
Clinical Immunology
In the same journal
Journal of Hepatology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 151 hits
ReferencesLink to record
Permanent link

Direct link